Pediatric Cardiology

Heart Surgery in India and UAE | Complete Patient Guide

Q: What is the cost of Paediatric Heart Surgery in India compared to the UAE?

The cost of paediatric heart surgery depends significantly on the complexity of the cardiac defect and the STAT risk category assigned to the procedure. In India, total costs — covering surgeon fees, operating theatre, cardiopulmonary bypass perfusion, PCICU stay, step-down ward stay, standard medications, and follow-up echocardiography — typically range from USD 4,000 to USD 18,000. A straightforward ASD or VSD repair with transcatheter device closure costs approximately USD 4,000–7,000, while complex open-heart operations such as Arterial Switch for TGA, Tetralogy of Fallot repair, or Fontan completion range from USD 10,000–18,000. In the UAE (Dubai and Abu Dhabi), equivalent procedures cost between USD 12,000 and USD 45,000, reflecting the premium hospitality infrastructure, boutique ICU nurse-to-patient ratios, and higher operational costs. India is typically 50–65% less expensive than the UAE for identical procedures performed by surgeons with equivalent international training and outcomes data. GAF Healthcare provides a fully itemised cost estimate before any commitment to travel, with no hidden facility, consumable, or administrative charges.

Q: How long does my child need to stay in the country before being fit to fly home?

The minimum safe in-country stay before international air travel is generally 6–8 weeks from the date of surgery, though this varies by procedural complexity and the child's individual recovery trajectory. For simple catheter-based interventions (ASD device closure, balloon valvuloplasty), fit-to-fly clearance may be granted as early as 3–5 days post-procedure after confirming no residual defect, pleural effusion, or arrhythmia by echocardiography and clinical review. For standard open-heart repairs (VSD, ASD, ToF repair) requiring median sternotomy, a minimum of 4–6 weeks is required to allow sternal healing and haemodynamic stabilisation on oral medications. For complex neonatal procedures (Norwood palliation, Arterial Switch Operation, TAPVR repair) or any child who required post-operative ECMO support, 6–8 weeks or longer is the norm, and a dedicated paediatric cardiologist clearance — including a formal echocardiogram, chest X-ray, and oxygen saturation confirmation — is mandatory before the GAF clinical team issues a fit-to-fly letter. Long-haul pressurised cabin travel requires cabin altitude equivalent to 6,000–8,000 feet, which reduces ambient oxygen partial pressure; children with residual cyanosis, pulmonary hypertension, or pleural effusions are at particular risk and may require supplemental in-flight oxygen arranged through the airline via a MEDIF form. GAF Healthcare manages all fit-to-fly documentation and, where indicated, arranges a trained medical escort for the return journey.

Q: What is the success rate of Paediatric Heart Surgery?

The success rate of paediatric heart surgery is highly procedure-specific and is formally stratified by the STS-EACTS Congenital Heart Surgery Mortality (STAT) scoring system across five complexity categories. For low-complexity procedures (STAT Category 1), which includes isolated ASD closure, small-to-moderate VSD repair, and simple pulmonary stenosis relief, operative survival exceeds 99% at experienced centres. Moderate-complexity repairs (STAT Category 2–3) — including complete Tetralogy of Fallot repair, AVSD correction, and coarctation with VSD — carry operative mortality rates of 1–4%, yielding survival rates of 96–99%. High-complexity operations (STAT Category 4–5) — including neonatal Arterial Switch Operation for TGA, TAPVR repair with obstruction, and Norwood Stage I palliation for HLHS — carry higher operative mortality of 5–15% at average centres, but the highest-volume programmes in India and GAF Healthcare's UAE partners report mortality rates at the lower end of this range (5–8% for Norwood, <2% for ASO) due to case volume experience and dedicated neonatal cardiac ICU protocols. The IQIC (International Quality Improvement Collaborative for Congenital Heart Disease) benchmarks outcomes from developing and middle-income country centres; hospitals within GAF Healthcare's network that participate in IQIC demonstrate operative mortality figures consistent with or below international medians for each STAT category. Long-term survival is excellent for biventricular repair patients, with 20-year survival exceeding 90% for ToF and 85% for TGA post-ASO. Single-ventricle Fontan patients have more variable long-term outcomes, with 10-year transplant-free survival of approximately 80–85% at specialised centres. GAF Healthcare will share the specific procedural outcome data from the recommended hospital for your child's diagnosis prior to any travel commitment.

Paediatric heart surgery encompasses a spectrum of open-heart, closed-heart, and hybrid interventional procedures performed to correct congenital and acquired cardiac defects in neonates, infants, children, and adolescents. Leading centres in India and the UAE report procedural success rates exceeding 95% for low-to-moderate complexity repairs, with world-class paediatric cardiac teams performing thousands of cases annually. GAF Healthcare connects international families to JCI- and NABH-accredited hospitals in India and JCI- and DHA-accredited hospitals in the UAE, managing every step from diagnosis review to post-operative repatriation so that parents can focus entirely on their child's recovery.

Hospital Stay

10–20 days

Success Rate

92%

Available in

India

Heart Surgery in India

Get Heart Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.

Heart Surgery in UAE

Heart Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.

Overview

Hospital Stay: 7–21 days (varies by complexity: neonatal single-ventricle palliation may require up to 4 weeks in ICU/step-down) • Total Stay in Country (Fit-to-Fly): 4–8 weeks from surgery date (6 weeks minimum for pressurised cabin travel following open sternotomy; neonates and single-ventricle patients require cardiologist clearance before boarding) • Success Rate: 93–97% (procedure-dependent; >97% for isolated VSD/ASD closure; 90–94% for complex biventricular repair; 85–92% for single-ventricle staged palliation)

What Is It?

Congenital heart disease (CHD) is the most common birth defect worldwide, affecting approximately 8–10 per 1,000 live births. Structural anomalies range from simple septal defects — ventricular septal defect (VSD), atrial septal defect (ASD), and patent ductus arteriosus (PDA) — to complex cyanotic lesions such as Tetralogy of Fallot (ToF), Transposition of the Great Arteries (TGA), Hypoplastic Left Heart Syndrome (HLHS), Total Anomalous Pulmonary Venous Return (TAPVR), and Truncus Arteriosus. Physiologically, these defects alter haemodynamic flow patterns, create intracardiac shunting, elevate pulmonary vascular resistance, and — if left uncorrected — progress to Eisenmenger physiology, ventricular failure, arrhythmia, and death. Acquired paediatric cardiac conditions, including rheumatic heart disease, infective endocarditis sequelae, and paediatric cardiomyopathies requiring surgical intervention, also fall within this surgical domain.

The global standard of care for most CHD lesions is anatomic correction or physiologic repair during infancy or early childhood, ideally before irreversible pulmonary hypertension develops. Risk stratification is formally quantified using the ARISTOTLE Comprehensive Complexity (ACC) score and the Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery (STS-EACTS) Congenital Heart Surgery Mortality Score (STAT category 1–5), guiding operative timing and resource allocation. Cardiopulmonary bypass (CPB) with deep hypothermic circulatory arrest (DHCA), modified ultrafiltration, and myocardial protection strategies using del Nido cardioplegia solution represent current intraoperative standards that have significantly reduced neurological sequelae and postoperative low-cardiac-output syndrome.

Both India and the UAE have invested heavily in dedicated paediatric cardiac centres of excellence. India's high-volume programmes — some performing over 2,000 CHD surgeries annually — provide unmatched surgical experience across the full STAT complexity spectrum. UAE centres, particularly in Dubai and Abu Dhabi, offer boutique-scale programmes with luxury infrastructure, internationally trained surgeons, and seamless access for families from the GCC, East Africa, and Europe. GAF Healthcare's network includes only hospitals whose paediatric cardiac outcomes are benchmarked against international registries such as the International Quality Improvement Collaborative (IQIC) for CHD.

Candidates

• Neonates (0–28 days) with ductal-dependent lesions (e.g., critical pulmonary stenosis, coarctation of the aorta, HLHS) requiring emergency or urgent palliation within days of diagnosis

• Infants (1–12 months) with large VSDs, complete atrioventricular septal defects (AVSD — especially in Down syndrome), TGA post-balloon atrial septostomy (BAS) stabilisation, or TAPVR with obstruction

• Children (1–18 years) with unrepaired or palliated CHD, residual lesions after prior surgery, or acquired cardiac conditions (rheumatic mitral/aortic valve disease, endocarditis-related valve destruction)

• Patients with Tetralogy of Fallot requiring complete intracardiac repair (VSD patch closure + RVOT reconstruction) after prior systemic-to-pulmonary shunt (Blalock–Thomas–Taussig shunt)

• Candidates for staged single-ventricle palliation: Norwood/Sano procedure (Stage I), Bidirectional Glenn (Stage II), and Fontan completion (Stage III)

• Children requiring pulmonary valve replacement (PVR) after ToF repair with severe pulmonary regurgitation and RV dilatation, including transcatheter pulmonary valve implantation (TPVI) via Melody or SAPIEN XT valve

• Paediatric patients needing cardiac re-operation (conduit change, baffle revision, pacemaker implantation)

• REQUIRED PRE-OPERATIVE DIAGNOSTICS: Transthoracic echocardiography (TTE) with colour Doppler and 3D reconstruction; cardiac catheterisation with haemodynamic assessment (Qp:Qs ratio, PVR index in Wood units) for borderline operative candidates; cardiac MRI (CMR) for ventricular volumetry and myocardial fibrosis mapping; CT angiography (CTA) for vascular anatomy delineation in complex lesions; genetic karyotyping and chromosomal microarray (FISH for 22q11.2 deletion in conotruncal defects); baseline full blood count, coagulation profile, metabolic panel, and renal/hepatic function; pulse oximetry saturation monitoring in all four limbs

• CONTRAINDICATIONS / INOPERABILITY CRITERIA: Fixed pulmonary arterial hypertension with PVRi >8 Wood units·m² unresponsive to vasodilator testing (oxygen, nitric oxide, iloprost); severe multiorgan dysfunction not attributable to cardiac cause; active systemic sepsis without source control; parental/guardian refusal after full informed consent; extreme prematurity or comorbidity profile placing perioperative mortality risk at near-100% (STAT Category 5 equivalent with additional non-cardiac comorbidities)

Procedure

CLOSED-HEART AND INTERVENTIONAL PROCEDURES (without cardiopulmonary bypass):

• Patent Ductus Arteriosus (PDA) ligation or thoracoscopic clip occlusion via video-assisted thoracoscopic surgery (VATS) — minimally invasive, no CPB, same-day extubation in eligible infants

• Coarctation of the aorta repair: subclavian flap aortoplasty, resection with end-to-end anastomosis, or balloon angioplasty/stenting in older children via cardiac catheterisation

• Blalock–Thomas–Taussig (BTT) modified shunt as palliative bridge in ductal-dependent cyanotic lesions

• Pulmonary artery banding (PAB) as staged palliation for large VSD with high pulmonary flow in low-weight infants

• Transcatheter device closure of ASD (Amplatzer Septal Occluder, Gore Cardioform) and VSD (Amplatzer Muscular VSD Occluder) under fluoroscopic and echocardiographic guidance — avoids sternotomy entirely

• Balloon pulmonary valvuloplasty and balloon aortic valvuloplasty for critical stenosis

• Transcatheter Pulmonary Valve Implantation (TPVI): Melody valve (Medtronic) or SAPIEN XT (Edwards) deployed percutaneously in patients with dysfunctional RV-to-PA conduits

OPEN-HEART SURGERY UNDER CARDIOPULMONARY BYPASS (CPB):

• VSD patch repair (Dacron or pericardial patch) — gold-standard repair with >99% closure rate in experienced hands

• ASD closure (primary suture or patch); sinus venosus ASD repair with SVC/IVC baffle

• Complete AVSD repair: single-patch, two-patch, or Australian technique (modified single-patch) with mitral valve cleft closure

• Tetralogy of Fallot complete repair: VSD closure + transannular patch or RV infundibulectomy ± pulmonary valvotomy; valve-sparing approaches preferred to preserve pulmonary valve competence

• Arterial Switch Operation (ASO / Jatene procedure) for TGA: great artery transection, coronary transfer, LeCompte manoeuvre — must be performed within first 2–3 weeks of life before LV regression

• Total Anomalous Pulmonary Venous Return (TAPVR) repair: pulmonary venous confluence-to-left-atrium anastomosis with ASD closure

• Fontan completion (extracardiac conduit or lateral tunnel technique) with fenestration option for high-risk candidates

• Norwood Stage I palliation (HLHS): atrial septectomy, neoaortic reconstruction using pulmonary artery homograft, and either a modified BTT shunt or Sano RV-to-PA conduit

• Ross Procedure: autologous pulmonary valve transposition to aortic position with RV-to-PA homograft reconstruction — preferred for paediatric aortic valve disease to allow somatic growth of the neoaortic root

• Mitral valve repair (annuloplasty, leaflet augmentation, chordal reconstruction) for rheumatic or congenital mitral disease; valve replacement with mechanical prosthesis (St. Jude Medical, On-X) or bioprosthesis when repair is not feasible

• Heart transplantation for end-stage cardiomyopathy or failed palliation (available at select centres in India and UAE)

HYBRID AND ADVANCED TECHNOLOGIES:

• Hybrid Stage I palliation (HLHS): combines surgical bilateral PAB and ductal stenting without CPB, reducing neonatal mortality in extremely high-risk neonates

• 3D-printed cardiac models derived from CTA/MRI data for pre-operative surgical simulation — adopted by leading centres in both India and UAE

• Intraoperative transoesophageal echocardiography (TOE/TEE) for real-time repair assessment before CPB separation

• Near-infrared spectroscopy (NIRS) cerebral oximetry monitoring during DHCA to minimise neurodevelopmental injury

• Extracorporeal Membrane Oxygenation (ECMO) — venoarterial (VA-ECMO) as bridge to recovery or transplant in post-operative low-cardiac-output syndrome or refractory cardiac arrest

• Robotic-assisted cardiac surgery in paediatrics remains investigational; limited to select adolescent ASD/mitral repairs at advanced centres

• Modified Ultrafiltration (MUF) post-CPB to reduce inflammatory mediators, improve myocardial function, and decrease transfusion requirements

Cost of Heart Surgery: India vs. UAE

The cost of paediatric heart surgery varies significantly by lesion complexity, STAT risk category, expected ICU duration, and whether staged or single-stage repair is performed. India offers the most cost-efficient access to globally benchmarked paediatric cardiac care, with all-inclusive costs typically 50–65% lower than equivalent procedures in the UAE. UAE centres in Dubai and Abu Dhabi command a premium reflecting luxury hospitality infrastructure, boutique patient-to-nurse ratios, and geographic convenience for GCC and European families. Both destinations offer transparent international patient pricing through GAF Healthcare, with no hidden facility or consumable fees.

Destination	Estimated Cost (USD)	Key Advantage
India	$4,000 – $18,000	~61% less than the UAE
UAE (Dubai/Abu Dhabi)	$12,000 – $45,000	Premium care, JCI/DHA accredited

Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.

Recovery & Aftercare

PHASE 1 — REMOTE PRE-CONSULTATION (Weeks –4 to –2 before travel): Families submit the child's complete medical records, echocardiography reports, catheterisation data, and prior operative notes through GAF Healthcare's secure portal. A senior paediatric cardiac surgeon and paediatric cardiologist from the receiving hospital conduct a video consultation to confirm diagnosis, recommend the surgical approach, assign a STAT category risk score, and provide a formal written operative plan and cost estimate. GAF Healthcare coordinates obtaining a second opinion if the family requests one.

PHASE 2 — PRE-OPERATIVE WORKUP ON ARRIVAL (Days 1–3): On arrival, the child is admitted to the paediatric cardiac centre. Repeat transthoracic echocardiography with 3D reconstruction, CTA or cardiac MRI (if not recently performed), full haematological and metabolic workup, chest X-ray, 12-lead ECG, and anaesthesia fitness assessment are completed. The paediatric cardiac intensivist, surgeon, anaesthetist, and perfusionist conduct a joint pre-operative case conference. Nutritional optimisation and, where indicated, prostaglandin E1 infusion (for ductal-dependent lesions) or diuresis management (for heart failure patients) begins immediately.

PHASE 3 — SURGERY DAY (Day 3–5): The child is brought to a dedicated paediatric cardiac theatre. Induction uses age-appropriate high-dose opioid-based anaesthesia (fentanyl or sufentanil) with ketamine for cyanotic patients. CPB is established via aortic and bicaval cannulation. Myocardial protection is achieved using del Nido or blood cardioplegia. Deep Hypothermic Circulatory Arrest (DHCA at 18°C) is employed when required for complex arch reconstruction. The specific repair is executed as planned. Intraoperative TOE confirms repair adequacy before chest closure. Modified ultrafiltration is performed after CPB separation. Delayed sternal closure (DSC) is employed in neonates and infants with significant myocardial oedema.

PHASE 4 — PAEDIATRIC CARDIAC ICU (PCICU) (Days 1–7 post-op, variable): The child is transferred intubated to the PCICU. Ventilator weaning follows standardised fast-track extubation protocols in stable patients (target extubation within 4–8 hours for simple repairs; 24–72 hours for complex cases). Haemodynamic monitoring includes arterial line, central venous pressure, and near-continuous NIRS. Milrinone, dopamine, or epinephrine infusions manage low-cardiac-output syndrome. Inhaled nitric oxide is available for pulmonary hypertensive crises. Chest drains, urinary catheter, and epicardial pacing wires are managed and progressively removed. Delayed sternal closure is performed at 24–72 hours when myocardial oedema resolves.

PHASE 5 — STEP-DOWN WARD (Days 7–14 post-op): Transfer from PCICU to a paediatric cardiac step-down ward. Oral feeding is re-established, chest physiotherapy begins, and mobilisation is encouraged in older children. Diuretics (furosemide, spironolactone), ACE inhibitors (enalapril or captopril for ventricular dysfunction), aspirin (for shunts and device closures), and anticoagulation (warfarin for mechanical valves — target INR 2.5–3.5) are commenced and optimised. Wound assessment and sternal healing are confirmed by clinical exam. Formal echocardiography is performed pre-discharge.

PHASE 6 — DISCHARGE AND IN-COUNTRY RECOVERY (Weeks 3–6): At hospital discharge, GAF Healthcare arranges serviced apartment or medical-grade accommodation close to the hospital for the family. Outpatient follow-up visits with the paediatric cardiologist occur at 1 and 4 weeks post-discharge. Repeat ECG, echocardiography, and laboratory tests (INR if on warfarin, electrolytes) are performed. Activity restrictions are explained: no sternal-loading activities (carrying, contact sport) for 6–8 weeks; swimming restricted until sternal healing confirmed (typically 8–12 weeks).

PHASE 7 — FIT-TO-FLY CLEARANCE AND REPATRIATION (Week 6–8): Formal fit-to-fly assessment is conducted by the paediatric cardiologist. Prerequisites include: haemodynamic stability on oral medications, oxygen saturation ≥92% (lesion-appropriate baseline), no pleural effusions or pneumothorax on chest X-ray, stable INR if anticoagulated, and confirmed wound healing. A detailed discharge summary, operative report, echocardiography report, medication list with dosing, and 3-month follow-up plan are provided in English and the family's native language. GAF Healthcare coordinates medical escort if required for complex neonatal or single-ventricle patients.

Risks & Considerations

Paediatric heart surgery carries inherent risks that are directly correlated with lesion complexity (STAT category), patient age and weight, and the presence of non-cardiac comorbidities (chromosomal anomalies, prematurity, renal dysfunction). Families must be fully counselled on the following: Low-cardiac-output syndrome (LCOS) occurs in 25–30% of neonatal open-heart cases and is managed with inotrope infusions (milrinone, epinephrine) and, in refractory cases, VA-ECMO support. Pulmonary hypertensive crisis — a sudden, dangerous rise in pulmonary vascular resistance — is managed with inhaled nitric oxide, high-dose oxygen, and alkalosis induction; it is most common in AVSD and TAPVR repairs. Neurological injury, ranging from subtle neurodevelopmental delay to overt stroke, remains the most feared long-term complication of prolonged DHCA; modern NIRS monitoring and selective antegrade cerebral perfusion have reduced but not eliminated this risk. Arrhythmias — particularly complete heart block (CHB) requiring permanent pacemaker implantation, occurring in 1–3% of AV node proximity repairs such as AVSD and VSD) — and junctional ectopic tachycardia (JET) in the early post-operative period are managed with amiodarone or active cooling. Residual or recurrent defects may necessitate catheter reintervention or re-operation; the lifetime re-intervention rate for complex CHD is 20–40%. Wound complications, mediastinitis, and sternal dehiscence occur in <2% of cases but require aggressive management. Renal failure requiring peritoneal dialysis or continuous renal replacement therapy (CRRT) affects approximately 5–8% of neonatal surgical patients. Bleeding requiring surgical re-exploration occurs in 3–5% of cases. All families should receive formal pre-operative counselling from the surgical team, and GAF Healthcare ensures this process includes a certified medical interpreter where required.

Mumbai, India

JCI NABH

Top Doctors for Heart Surgery

Why Plan Your Treatment Through Gaf Healthcare?

GAF Healthcare provides end-to-end non-medical coordination for international families travelling to India or the UAE for paediatric heart surgery, ensuring that logistical complexity never compounds clinical stress.

INDIA LOGISTICS: GAF Healthcare facilitates the Indian e-Medical Visa (e-MV) application for the patient and up to two accompanying guardians, including preparation of the hospital invitation letter, treatment cost estimate, and passport documentation required by the Indian Bureau of Immigration. e-Medical Visas are typically granted within 3–5 business days. The visa permits a 60-day stay, extendable in-country through the Foreigners Regional Registration Office (FRRO) if the child's recovery requires a longer stay. Airport transfers from all major international airports (Delhi IGI, Mumbai CSIA, Chennai MAA, Hyderabad HYD, Bangalore BLR) are arranged in medical-grade vehicles with child safety seats. GAF Healthcare assigns a dedicated patient coordinator who is present from airport arrival through discharge. Certified medical interpreters covering Arabic, French, Swahili, Russian, and other languages are arranged for daily clinical consultations. Serviced apartments and family guesthouses within 1–2 km of the treating hospital are pre-booked, including meals aligned with dietary requirements (halal, kosher, vegetarian). Currency exchange, SIM card procurement, and pharmacy runs are managed by the GAF care team.

UAE LOGISTICS: Citizens of most GCC states, Western Europe, North America, and many other countries receive visa-on-arrival or visa-free entry to the UAE for up to 30–90 days depending on passport nationality. GAF Healthcare pre-confirms entry eligibility for the patient's nationality and arranges prior visa coordination for nationalities requiring advance approval through the UAE General Directorate of Residency and Foreigners Affairs (GDRFA). UAE hospitals in GAF's network are located in Dubai (Dubai Health Authority — DHA regulated) and Abu Dhabi (Department of Health — DOH regulated), all JCI-accredited. Private medical insurance pre-authorisation for international policies is managed directly by GAF Healthcare's billing team. Airport transfers from Dubai International (DXB), Al Maktoum (DWC), and Abu Dhabi International (AUH) are arranged in climate-controlled, child-appropriate vehicles. Luxury serviced apartments and hotel-grade family suites adjacent to treating hospitals are available. Halal catering, Arabic-speaking coordinators, and 24-hour family support lines are standard.

ACROSS BOTH DESTINATIONS: GAF Healthcare provides families with a single point-of-contact coordinator available via WhatsApp, phone, and email around the clock throughout the child's treatment episode. Medical records are digitised and transmitted securely between treating and home-country physicians at discharge. A detailed repatriation plan — including fit-to-fly documentation, airline medical clearance letters (MEDIF/MEDA forms), wheelchair or stretcher assistance, and in-flight oxygen arrangement where clinically indicated — is prepared by the GAF clinical team before departure.

Patients Also Explore

Other treatments commonly sought by patients considering Heart Surgery.

Coronary Artery Bypass Grafting

Cardiology

Heart Valve Replacement

Cardiology

Gynecology & Obstetrics

Gynecology

Breast Biopsy

Gynecology

The arterial switch operation (TGA repair) in India costs USD 5,500–9,000 with a 94–97% survival rate. Complete guide covering the procedure, best hospitals, recovery timeline, and how GAF Healthcare coordinates surgery from abroad.

Read Guide